All the more publicity for this little sleeper. We are both set at a good entry.There was confidence about the efficacy of this drug all those years ago - so nothing has changed there. Just might be better managed this time.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025